Initially used for blood glucose control, the medications reduce cardiovascular events and mitigate heart failure ...

Medera is a clinical-stage biopharmaceutical company focused on targeting difficult-to-treat and currently incurable diseases ...

Growth hormone therapy improved exercise capacity, heart function, and quality of life in patients with HFrEF and growth ...

A new study published in the European Heart Journal showed that patients with myocardial infarction (MI) and preserved left ...

There is increased use of quadruple medical therapy among patients following implementation of an HF quality improvement initiative.

– For people who have heart failure with a normal heart rhythm, there seems to be little to no advantage of warfarin (an anticoagulant: a medicine which prevents blood clotting by blocking proteins) ...

Heating the lower limbs before exercise has been found to significantly improve endurance in individuals with heart failure.

Finerenone treatment vs placebo was associated with a reduced risk for new-onset diabetes by 24% among patients with HFmrEF or HFpEF.

Objective: This study aims to synthesize evidence on the cost-effectiveness of dapagliflozin for heart failure (HF) with all ejection fractions (EF), Including heart failure with reduced ejection ...

Simplified method using left atrial volume and natriuretic peptides streamlines diagnosis of heart failure with preserved ...

Heart failure with reduced ejection fraction (HFrEF) represents a significant global health burden, affecting over 64 million individuals and resulting in substantial morbidity and mortality, ...

Heart failure with preserved ejection fraction (HFpEF) is one of the most common forms of heart failure; its prevalence is increasing, and outcomes are worsening. Affected patients often experience ...